Literature DB >> 18761386

Impact of varicella vaccination on health care outcomes in Ontario, Canada: effect of a publicly funded program?

Jeffrey C Kwong1, Peter Tanuseputro, Brandon Zagorski, Rahim Moineddin, Kevin J Chan.   

Abstract

Varicella vaccines have been available for private purchase in Canada since 1998. Ontario introduced publicly funded varicella vaccination in 2004. We assessed the effects of private availability of varicella vaccines and subsequent implementation of a publicly funded vaccination program on varicella-related hospitalizations, emergency department (ED) use, and visits to physicians' offices in Ontario. Rates of hospitalizations, ED use, and office visits decreased 53% (95% CI, 48-58%), 43% (95% CI, 41-44%), and 45% (95% CI, 44-45%) after publicly funded vaccination, compared to only 9% (95% CI, 4-14%), 23% (95% CI, 22-24%), and 29% (95% CI, 28-29%) after private availability. Varicella vaccination is effective at reducing varicella-related health care use, with benefits extending beyond those who receive the vaccine. Publicly funded vaccination programs may be more effective than private vaccine availability.

Mesh:

Substances:

Year:  2008        PMID: 18761386     DOI: 10.1016/j.vaccine.2008.08.016

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  12 in total

1.  Evidence-based clinical guidelines for immigrants and refugees.

Authors:  Kevin Pottie; Christina Greenaway; John Feightner; Vivian Welch; Helena Swinkels; Meb Rashid; Lavanya Narasiah; Laurence J Kirmayer; Erin Ueffing; Noni E MacDonald; Ghayda Hassan; Mary McNally; Kamran Khan; Ralf Buhrmann; Sheila Dunn; Arunmozhi Dominic; Anne E McCarthy; Anita J Gagnon; Cécile Rousseau; Peter Tugwell
Journal:  CMAJ       Date:  2010-06-07       Impact factor: 8.262

2.  Zoster vaccination: A new opportunity for adult immunization.

Authors:  Kevin B Laupland; David N Fisman
Journal:  Can J Infect Dis Med Microbiol       Date:  2009       Impact factor: 2.471

3.  Varicella-related hospitalizations in the United States, 2000-2006: the 1-dose varicella vaccination era.

Authors:  Adriana S Lopez; John Zhang; Cedric Brown; Stephanie Bialek
Journal:  Pediatrics       Date:  2011-01-03       Impact factor: 7.124

4.  Varicella and herpes zoster hospitalizations before and after implementation of one-dose varicella vaccination in Australia: an ecological study.

Authors:  Anita E Heywood; Han Wang; Kristine K Macartney; Peter McIntyre
Journal:  Bull World Health Organ       Date:  2014-06-13       Impact factor: 9.408

5.  Varicella Vaccination Two-Dose Recommendations: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).

Authors:  Ben Tan; Shainoor Ismail
Journal:  Can Commun Dis Rep       Date:  2010-09-20

6.  The controversy of varicella vaccination in children with acute lymphoblastic leukemia.

Authors:  Miguela A Caniza; Stephen P Hunger; Andre Schrauder; Maria Grazia Valsecchi; Ching-Hon Pui; Giuseppe Masera
Journal:  Pediatr Blood Cancer       Date:  2010-09-16       Impact factor: 3.167

7.  A spot of bother: Why varicella vaccine programs matter.

Authors:  T Harris; C Y Seo; E Shing; K Wong; J Fediurek; S L Deeks
Journal:  Can Commun Dis Rep       Date:  2015-10-01

8.  Risk factors for susceptibility to varicella in newly arrived adult migrants in Canada.

Authors:  C Greenaway; J F Boivin; S Cnossen; C Rossi; B Tapiero; K Schwartzman; S Olson; M Miller
Journal:  Epidemiol Infect       Date:  2013-11-01       Impact factor: 4.434

9.  Twenty Years of Medically-Attended Pediatric Varicella and Herpes Zoster in Ontario, Canada: A Population-Based Study.

Authors:  Anne E Wormsbecker; Jun Wang; Laura C Rosella; Jeffrey C Kwong; Chi Yon Seo; Natasha S Crowcroft; Shelley L Deeks
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

10.  The Cost-Effectiveness of Universal Varicella Vaccination in Italy: A Model-Based Assessment of Vaccination Strategies.

Authors:  C Azzari; V Baldo; S Giuffrida; R Gani; E O'Brien; C Alimenti; V J Daniels; L J Wolfson
Journal:  Clinicoecon Outcomes Res       Date:  2020-06-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.